Meet the Mobetron

Our flagship product—the Mobetron—is used by the leading cancer physicians in the best hospitals, clinics and academic centers in the world.

The Mobetron is the first mobile, self-shielded electron linear accelerator (LINAC) designed to deliver Intraoperative Radiation Therapy (IORT) to cancer patients during surgery. This innovation brings safe, reliable and portable to the operating room without the need for costly shielding renovations or retrofits. And in turn, Mobetron underscores IntraOp’s commitment to providing a bottom-line solution designed to maximize ROI, reduce risk, and leverage a competitive advantage for cancer centers and their patients alike.

IntraOp Mobetron

Benefits at a Glance

BROAD APPLICATION

Proven success with multiple indications of cancer

PORTABLE

Offers flexible movement within and between OR suites

PRECISE

Electron-beam IORT delivers radiation to only involved tissue

SHORTER TREATMENT

Two minutes during surgery replaces weeks of therapy

FEWER SIDE EFFECTS

Direct dose to tumor bed avoids healthy tissue and organs

LOWER RECURRENCE RATES

Proven success and increased survival rates

SELF-SHIELDED

Avoids adding costly shielding
to the OR

MADE IN AMERICA

Mobetron is designed and built in Silicon Valley California

COST-EFFECTIVE

Let us show you the Mobetron value proposition

The End of the Shielded OR

Consider the scene before the Mobetron: a patient undergoing surgery is required transport to a shielded radiation bunker only to be returned after treatment for the remainder of the surgery. The method was inefficient for oncologists and it added costs for the hospital. Worse, it introduced greater risk for the patient.

Fast forward. By making electrons portable, the Mobetron leverages the advantages of IORT without sacrificing effectiveness. Radiation and surgical oncologists are now enabled to work together to pinpoint the exact area requiring radiation and immediately deliver high doses directly to the affected tissue during cancer surgery. Healthy tissue and surrounding organs remain unaffected. Portability means that the Mobetron can easily be moved between existing operating rooms without investing in costly renovations to accommodate traditional unshielded radiation therapy devices. The treatment is brought to the patient. The procedure is completed in a fraction of the time with fewer side effects and lower rates of recurrence. Most importantly, the patient can go on living. Longer.

The Mobetron Demonstration

Mobetron has fundamentally changed the way we treat cancer patients at our facility. We have been able to eradicate localized cancers, prevent recurrent cancers, shorten treatment cycles and save patients. Mobetron is a critical tool in the fight against cancer."

Dr. Daphne Hass-Kogan

Professor of Radiation Oncology and Neurological Surgery, Program Director and Vice Chair, Department of Radiation Oncology. Mt. Zion Cancer Center, University of California at San Francisco (UCSF)

Mobetron Datasheet

An overview of history, application and techincal specifications.

Download Datasheet

Mobetron was the ideal solution for University Hospitals Case Medical Center. Our radiation and surgical oncology teams were intent on using electron-beam iort. Because the device was self-shielded and completely portable, we were able to deploy it in an existing operating room and save millions of dollars in special construction costs.”

Timothy J. Kinsella

MD Chairman and Professor, Department of Radiation Oncology, University Hospitals Case Medical Center, Cleveland, Ohio

Mobetron Treatment Locations Photo

Mobetron Treatment Locations

Find the Mobetron treatment location nearest to you.

Find a Mobetron
Mobetron Patient Testimonial

Patient Success Stories

Short bit of copy that says something about hope.

See Survivor Stories